Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
4
×
boston top stories
clinical trials
drugs
4
×
life sciences
national blog main
national top stories
new york blog main
new york top stories
fda
san diego blog main
san diego top stories
boulder/denver blog main
boulder/denver top stories
cancer
detroit blog main
detroit top stories
indiana blog main
indiana top stories
merck
national
pfizer
raleigh-durham blog main
raleigh-durham top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
4d molecular therapeutics
abbvie
acne
agenus
akcea therapeutics
allopregnanolone
anylam pharmaceuticals
astrazeneca
What
approved
4
×
drug
fda
oks
disease
genetic
medicine
new
ago
akcea
alnylam
amyloidosis
attr
available
battle
bio
brexanolone
cancer
companies
debilitating
deeper
depression
devastating
digital
disorder
dna
epidemic
fast
fatty
fingerprint
frenzied
going
growing
known
led
liver
matter
medicines
merck
moms
Language
Current search:
approved
×
drugs
×
" boston blog main "
×
@xconomy.com
4 years ago
FDA OKs Pfizer Rare Disease Drug, Sets Up Battle With Alnylam, Akcea
@xconomy.com
5 years ago
FDA OKs Depression Drug For New Moms: Fast Relief But Tough to Take
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues
